Reference
Zhao H, et al. Pyrotinib for HER2-amplified non-small cell lung cancer patient after progression to Afatinib: a case report. Anti-Cancer Drugs 33: 509-512, No. 5, Jun 2022. Available from: URL: http://doi.org/10.1097/CAD.0000000000001298
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1917, 29 (2022). https://doi.org/10.1007/s40278-022-19900-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19900-7